← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sequela
Falmouth, ME
$6,473,226
Total funding
4
Grants
Funding over time
peak $989.3K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$6,473,226 · 4
By mechanism
R44$5,477,157 · 2
R43$996,069 · 2
Investigators at Sequela
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
NOVEL ASSAY TO DETECT CHRONIC KIDNEY DISEASE$989,285
R44 · FY2015 · DK
NOVEL ASSAY TO DETECT CHRONIC KIDNEY DISEASE$965,044
R44 · FY2016 · DK
BIOMARKER FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE$955,511
R44 · FY2012 · DK
NOVEL ASSAY TO DETECT CHRONIC KIDNEY DISEASE$933,270
R44 · FY2017 · DK
BIOMARKER FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE$535,755
R44 · FY2013 · DK
A Test for Salt Sensitivity in People with Essential Hypertension$504,066
R44 · FY2008 · DK
A Test for Salt Sensitivity in People with Essential Hypertension$410,387
R44 · FY2009 · DK
Biomarker for Early Detection of Chronic Kidney Disease$317,351
R43 · FY2010 · DK
Biomarker for Early Detection of Chronic Kidney Disease$275,076
R43 · FY2011 · DK
A Uroguanylin Based ELISA for Salt Sensitivity$213,442
R43 · FY2005 · DK
A Uroguanylin Based ELISA for Salt Sensitivity$190,200
R43 · FY2006 · DK
BIOMARKER FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE$183,839
R44 · FY2014 · DK